Showing results (1241-1250 of 2,904) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|August 28, 2010
Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancerJ J Cody, A A Rivera, G R Lyons, et al.Cancer Gene Therapy|June 5, 2010
Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomasI M Germano, L Emdad, Z A Qadeer, et al.Cancer Gene Therapy|May 22, 2010
Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors producedX-Q Zhang, K Dunner, W F BenedictCancer Gene Therapy|May 15, 2010
Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase geneC-K Tai, W Wang, Y-H Lai, et al.Cancer Gene Therapy|May 8, 2010
Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenovirusesN Höti, W H Chowdhury, S Mustafa, et al.Cancer Gene Therapy|May 8, 2010
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transferG Wang, J Qiu, R Wang, et al.Cancer Gene Therapy|February 25, 2006
SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in miceC Kimchi-Sarfaty, W D Vieira, D Dodds, et al.Cancer Gene Therapy|October 21, 2006
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-mycL C Boffa, G Cutrona, M Cilli, et al.Cancer Gene Therapy|December 20, 2008
Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor modelZ Li, J Xiang, W Zhang, et al.Cancer Gene Therapy|December 20, 2008
Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunityJ Xiang, M A Munegowda, Y DengPageof 291